Skip to content

Author

I. Vascotto

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Nov 2026

Trastuzumab deruxtecan in HER2-expressing urothelial carcinoma: current evidence, biomarker challenges, and future therapeutic strategies.

INTRODUCTION Urothelial carcinoma (UC) has become a prototype for antibody-drug conjugate (ADC)-based therapy, but relapse after first-line enfortumab vedotin plus pembrolizumab remains common. HER2 protein expression, ERBB2 amplification and activating mutations identify overlapping but distinct populations; this revi...

G. Roviello, K. Shtembari, I. Vascotto et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.